In the highly regulated field of medical technology, communications from a supervisory authority, such as Swissmedic, can arise without warning, compelling manufacturers or other economic operators to take immediate action. Often, companies are not adequately prepared to handle these situations.
Based on our experience, the urgency and potential consequences of such regulatory interventions are frequently underestimated.